CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) announces the development of the Rejuvenescence Chip, a revolutionary anti-aging device that combines phytocannabinoids and gestrinone. The company holds 13 patents and continues expanding its intellectual property portfolio. The chip offers controlled release of active ingredients for aesthetic, hormonal, and sexual health benefits. Features include improved skin elasticity, reduced fat accumulation, increased muscle mass, hormonal regulation, and enhanced sexual well-being. Dr. Jennifer Salguero explains that treatment requires blood analysis for personalized hormone and endocannabinoid formulation.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) annuncia lo sviluppo del Rejuvenescence Chip, un dispositivo rivoluzionario anti-invecchiamento che combina fitocannabinoidi e gestrinone. L'azienda detiene 13 brevetti e continua ad ampliare il proprio portafoglio di proprietà intellettuale. Il chip offre un rilascio controllato di ingredienti attivi per benefici estetici, ormonali e sessuali. Le caratteristiche includono un miglioramento dell'elasticità della pelle, una riduzione dell'accumulo di grasso, un aumento della massa muscolare, la regolazione ormonale e un benessere sessuale potenziato. La Dott.ssa Jennifer Salguero spiega che il trattamento richiede un'analisi del sangue per una formulazione personalizzata degli ormoni e dell'endocannabinoide.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) anuncia el desarrollo del Rejuvenescence Chip, un dispositivo revolucionario contra el envejecimiento que combina fitocannabinoides y gestrinona. La compañía posee 13 patentes y continúa ampliando su cartera de propiedad intelectual. El chip ofrece liberación controlada de ingredientes activos para beneficios estéticos, hormonales y sexuales. Las características incluyen mejora de la elasticidad de la piel, reducción de la acumulación de grasa, aumento de la masa muscular, regulación hormonal y bienestar sexual mejorado. La Dra. Jennifer Salguero explica que el tratamiento requiere un análisis de sangre para una formulación personalizada de hormonas y endocannabinoides.
칸나비스 바이오사이언스 인터내셔널 홀딩스(Cannabis Bioscience International Holdings) (OTCMKTS: CBIH)가 피토카나비노이드와 게스트리논(gestrinone)을 결합한 혁신적인 항노화 장치인 Rejuvenescence Chip의 개발을 발표했습니다. 이 회사는 13개의 특허를 보유하고 있으며 지식 재산 포트폴리오를 계속 확장하고 있습니다. 이 칩은 미용, 호르몬, 성 건강을 위한 활성 성분의 저조적 방출을 제공합니다. 기능으로는 피부 탄력 개선, 지방 축적 감소, 근육량 증가, 호르몬 조절 및 강화된 성적 웰빙이 포함됩니다. 제니퍼 살게로 박사는 치료를 위해 개인 맞춤형 호르몬 및 내인성 칸나비노이드 조성을 위한 혈액 분석이 필요하다고 설명합니다.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) annonce le développement de la Rejuvenescence Chip, un dispositif anti-âge révolutionnaire qui combine des phytocannabinoïdes et de la gestrinone. L'entreprise détient 13 brevets et continue d'élargir son portefeuille de propriété intellectuelle. La puce offre un relâchement contrôlé des ingrédients actifs pour des bénéfices esthétiques, hormonaux et sexuels. Ses caractéristiques incluent une amélioration de l'élasticité de la peau, une réduction de l'accumulation de graisse, une augmentation de la masse musculaire, la régulation hormonale et un bien-être sexuel accru. Dr. Jennifer Salguero explique que le traitement nécessite une analyse sanguine pour une formulation personalisée des hormones et des endocannabinoïdes.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) kündigt die Entwicklung des Rejuvenescence Chip an, ein revolutionäres Anti-Aging-Gerät, das Phytocannabinoide und Gestorinone kombiniert. Das Unternehmen hält 13 Patente und erweitert weiterhin sein Portfolio an geistigem Eigentum. Der Chip bietet eine kontrollierte Freisetzung von Wirkstoffen für ästhetische, hormonelle und sexuelle Gesundheitsvorteile. Zu den Merkmalen gehören verbesserte Hautelastizität, reduzierte Fettansammlungen, erhöhte Muskelmasse, hormonelle Regulierung und verbessertes sexuelles Wohlbefinden. Dr. Jennifer Salguero erklärt, dass die Behandlung eine Blutuntersuchung für eine personalisierte Hormon- und Endocannabinoid-Formulierung erfordert.
- Holds 13 patents demonstrating strong intellectual property portfolio
- Developed innovative Rejuvenescence Chip technology combining phytocannabinoids and gestrinone
- Offers personalized treatment approach through blood analysis
- Product still in development phase without market approval
- No timeline provided for commercialization
- No financial or market size projections provided
HOUSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) continues to set a standard in innovation with unparalleled momentum in intellectual property development. The company proudly stands with a remarkable portfolio of 13 unconventional patents.
In addition, our Research and Development team is redefining the possibilities of cannabinoid-based biotechnologies and at the heart of these innovations lies the Rejuvenescence Chip, a pioneering advancement in anti-aging medicine.
This cutting-edge device redefines wellness by delivering a controlled release of active ingredients combining phytocannabinoids and gestrinone, offering a long-term solution for aesthetics, hormonal health, and sexual well-being.
In the realm of aesthetics, it promotes improved skin elasticity and appearance, reduces fat accumulation, increases lean muscle mass, and boosts vitality and energy. Hormonally, it helps regulate menstrual cycles, alleviates premenstrual and menopausal symptoms such as hot flashes, night sweats, and insomnia, and restores balance in women with low progesterone levels.
For sexual health, it enhances libido, improves sexual response, and elevates mood and overall quality of life. Additionally, its anti-inflammatory properties provide protection against estrogen-dominance-related conditions, such as endometriosis.
Beyond these physical benefits, the treatment supports emotional well-being, instilling confidence and vitality in women, empowering them to feel more in control of their personal lives, and fostering deeper, more fulfilling relationships, enhancing both individual well-being and interpersonal connection.
“This tailored-made medication would require a comprehensive analysis of the patient’s blood samples to determine the precise levels of hormones and endocannabinoids,” explains Dr. Jennifer Salguero, PhD, R&D Coordinator at CBIH. “Based on this analysis, we can customize the chip’s formulation and deliver a personalized dosage of specific compounds to restore balance and promote rejuvenation.”
CBIH remains committed to advancing the patent for this revolutionary anti-ageing technology and continues to push the boundaries of cannabinoid therapy in cosmetics and pharmaceuticals. By leveraging next-generation technology, CBIH is setting new standards for therapeutic advancements and is poised to lead the charge in unlocking the full potential of cannabinoids in both medicine and beauty.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words “believe,” “expect,” “should,” “intend,” “estimate,” “projects,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
FAQ
What is CBIH's Rejuvenescence Chip and how does it work?
How many patents does Cannabis Bioscience International Holdings (CBIH) currently hold?
What are the main benefits of CBIH's Rejuvenescence Chip?
